PL-7 positive antisynthetase syndrome and pulmonary hypertension

Journal of Rheumatology

Volumn 40, Issue 10, 2013, Pages 1777-1779

  Foris, Vasile ^a   Kovacs, Gabor ^a   Matucci Cerinic, Marco ^b   Olschewski, Horst ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANTIBODY; C REACTIVE PROTEIN; CREATINE KINASE; CYCLOSPORIN; FUROSEMIDE; OXYGEN; PL 7 ANTIBODY; PREDNISOLONE; SILDENAFIL; SPIRONOLACTONE; TIOTROPIUM BROMIDE; UNCLASSIFIED DRUG;

AGED; ANTISYNTHETASE SYNDROME; CARDIOMEGALY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DELAYED DIAGNOSIS; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRY THROAT; DYSPNEA; EXERCISE TOLERANCE; FEMALE; FEVER; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GLOMERULUS FILTRATION RATE; GOUT; HEART CATHETERIZATION; HUMAN; INTERSTITIAL LUNG DISEASE; LETTER; LUNG ARTERY PRESSURE; LUNG FIBROSIS; LUNG WEDGE PRESSURE; NIGHT SWEAT; OXYGEN THERAPY; PHYSIOTHERAPY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; THORAX RADIOGRAPHY; WEIGHT REDUCTION;

AGED; AUTOANTIBODIES; FEMALE; HUMANS; HYPERTENSION, PULMONARY; MYOSITIS;

EID: 84885170175     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.130403     Document Type: Letter

References (8)

1. Stanciu R, Guiguet M, Musset L, Touitou D, Beigelman C, Rigolet A, et al. Antisynthetase syndrome with anti-Jo1 antibodies in 48 patients: pulmonary involvement predicts disease-modifying antirheumatic drug use. J Rheumatol 2012;39:1835-9.
2. Mathews MB, Reichlin M, Hughes GR, Bernstein RM. Anti-threonyl-tRNA synthetase, a second myositis-related autoantibody. J Exp Med 1984;160:420-34.
3. Fischer A, Swigris JJ, Du Bois RM, Lynch DA, Downey GP, Cosgrove GP, et al. Anti-synthetase syndrome in ANA and anti-Jo-1 negative patients presenting with idiopathic interstitial pneumonia. Respir Med 2009;103:1719-24.
4. Hervier B, Devilliers H, Stanciu R, Meyer A, Uzunhan Y, Masseau A, et al. Hierarchical cluster and survival analyses of antisynthetase syndrome: phenotype and outcome are correlated with anti-tRNA synthetase antibody specificity. Autoimmun Rev 2012;12:210-7.
5. Marie I, Josse S, Decaux O, Dominique S, Diot E, Landron C, et al. Comparison of long-term outcome between anti-Jo1-and anti-PL7/PL12 positive patients with antisynthetase syndrome. Autoimmun Rev 2012;11:739-45.
6. Labirua-Iturburu A, Selva-O'Callaghan A, Vincze M, Dankó K, Vencovsky J, Fisher B, et al. Anti-PL-7 (anti-threonyl-tRNA synthetase) antisynthetase syndrome: clinical manifestations in a series of patients from a European multicenter study (EUMYONET) and review of the literature. Medicine 2012;91:206-11.
7. Hervier B, Uzunhan Y, Hachulla E, Benveniste O, Nunes H, Delaval P, et al. Antisynthetase syndrome positive for anti-threonyl-tRNA synthetase (anti-PL7) antibodies. Eur Respir J 2011;37:714-7.
8. Hervier B, Meyer A, Dieval C, Uzunhan Y, Devilliers H, Launay D, et al. Pulmonary hypertension in antisynthetase syndrome: prevalence, etiology and survival. Eur Respir J 2013; Feb. 8 (E-pub ahead of print).